Related references
Note: Only part of the references are listed.Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Renato V. Iozzo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The Insulin-Like Growth Factor Receptor I Promotes Motility and Invasion of Bladder Cancer Cells through Akt- and Mitogen-Activated Protein Kinase-Dependent Activation of Paxillin
David Metalli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
Achilleas D. Theocharis et al.
FEBS JOURNAL (2010)
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans
Renato V. Iozzo et al.
FEBS JOURNAL (2010)
Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels
Simone Buraschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells
Barbara Salani et al.
PLOS ONE (2010)
Proepithelin Regulates Prostate Cancer Cell Biology by Promoting Cell Growth, Migration, and Anchorage-Independent Growth
Giada Monami et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Molecular Pathogenesis and Diagnostics of Bladder Cancer
Anirban P. Mitra et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Proepithelin is an autocrine growth factor for bladder cancer
Francesca Lovat et al.
CARCINOGENESIS (2009)
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Sherryline Jogie-Brahim et al.
ENDOCRINE REVIEWS (2009)
Decorin is a novel antagonistic ligand of the Met receptor
Silvia Goldoni et al.
JOURNAL OF CELL BIOLOGY (2009)
Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line
Kentaro Araki et al.
ONCOLOGY (2009)
Decorin Suppresses Prostate Tumor Growth through Inhibition of Epidermal Growth Factor and Androgen Receptor Pathways
Yunping Hu et al.
NEOPLASIA (2009)
An antimetastatic role for decorin in breast cancer
Silvia Goldoni et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation
Xiuli Bi et al.
CARCINOGENESIS (2008)
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Meenali M. Chitnis et al.
CLINICAL CANCER RESEARCH (2008)
Decorin-Mediated Inhibition of Proliferation and Migration of the Human Trophoblast via Different Tyrosine Kinase Receptors
D. Iacob et al.
ENDOCRINOLOGY (2008)
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs
Silvia Goldoni et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Molecular pathogenesis of bladder cancer
Margaret A. Knowles
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of α2β1 integrin activity
Lorna R. Fiedler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction
Liliana Schaefer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Grb10/Nedd4-mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization
Giada Monami et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-κB and snail
Hyun-Jung Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and mammalian target of rapamycin
Liliana Schaefer et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation
Daniela G. Seidler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Decorin binds myostatin and modulates its activity to muscle cells
T Miura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis
JX Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder
H Miyake et al.
BJU INTERNATIONAL (2005)
Decorin, a novel player in the insulin-like growth factor system
E Schönherr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Decorin prevents metastatic spreading of breast cancer
CC Reed et al.
ONCOGENE (2005)
Biologically active decorin is a monomer in solution
S Goldoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Integrin signalling during tumour progression
WJ Guo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
DR Rhodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model
A Biglari et al.
CANCER GENE THERAPY (2004)
Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
L Dyrskjot et al.
CANCER RESEARCH (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor
A Vecchione et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Decorin binds fibrinogen in a Zn2+-dependent interaction
TA Dugan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dysregulation of the annexin family protein family is associated with prostate cancer progression
W Xin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
In vivo selective and distant killing of cancer cells, using adenovirus-mediated decorin gene transfer
JG Tralhao et al.
FASEB JOURNAL (2003)
Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope
M Santra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
IRS proteins and the common path to diabetes
MF White
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin
CC Reed et al.
ONCOGENE (2002)
The contradictions of the insulin-like growth factor 1 receptor
R Baserga
ONCOGENE (2000)
An anti-oncogenic role for decorin - Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells
M Santra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sustained down-regulation of the epidermal growth factor receptor by decorin -: A mechanism for controlling tumor growth in vivo
G Csordás et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1
T Haruta et al.
MOLECULAR ENDOCRINOLOGY (2000)
Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor
D Le Roith
GROWTH HORMONE & IGF RESEARCH (2000)
Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3 '-kinase inhibition
AV Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)